Stock comparison
IDEXX Laboratories
UFP Technologies
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
IDXX
IDEXX Laboratories
Market cap
$44.12B
Sector
Healthcare
UFPT
UFP Technologies
Market cap
$1.77B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | IDXX | UFPT | Winner |
|---|---|---|---|
| Warren Buffett | 75B | 64C | IDXX |
| Benjamin Graham | 80A | 79B | IDXX |
| Philip Fisher | 75B | 64C | IDXX |
| Peter Lynch | 71B | 62C | IDXX |
| Joel Greenblatt | 83C | 43D | IDXX |
| Charlie Munger | 87A | 50C | IDXX |
| Terry Smith | 84A | 52D | IDXX |
Side-by-side metrics
| Metric | IDXX | UFPT |
|---|---|---|
| Market cap | $44.12B | $1.77B |
| P/E (TTM) | 39.0x | 24.4x |
| EV/EBIT | 31.6x | 19.7x |
| ROIC (TTM) | 40.66% | 12.31% |
| Gross margin | 62.05% | 28.35% |
| Net margin | 24.63% | 11.27% |
| Revenue CAGR 5y | 7.56% | 30.74% |
| EPS CAGR 5y | 10.79% | 43.19% |
| Debt / Equity | 0.7x | 0.4x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IDXX leads on
- Market cap$44.12Bvs $1.77B+96%
- ROIC (TTM)40.66%vs 12.31%+70%
- Gross margin62.05%vs 28.35%+54%
- Net margin24.63%vs 11.27%+54%
UFPT leads on
- Revenue CAGR 5y30.74%vs 7.56%+75%
- EPS CAGR 5y43.19%vs 10.79%+75%
- Debt / Equity0.4xvs 0.7x+49%
- EV/EBIT19.7xvs 31.6x+38%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.